Cargando…
Idarucizumab: A novel antidote for reversal of dabigatran
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732247/ https://www.ncbi.nlm.nih.gov/pubmed/26889284 http://dx.doi.org/10.4103/1793-5482.165795 |
| _version_ | 1782412676394123264 |
|---|---|
| author | Rehman, Abdul Awais, Muhammad Baloch, Noor Ul-Ain |
| author_facet | Rehman, Abdul Awais, Muhammad Baloch, Noor Ul-Ain |
| author_sort | Rehman, Abdul |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4732247 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2016 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-47322472016-02-17 Idarucizumab: A novel antidote for reversal of dabigatran Rehman, Abdul Awais, Muhammad Baloch, Noor Ul-Ain Asian J Neurosurg Letter to Editor Medknow Publications & Media Pvt Ltd 2016 /pmc/articles/PMC4732247/ /pubmed/26889284 http://dx.doi.org/10.4103/1793-5482.165795 Text en Copyright: © Asian Journal of Neurosurgery http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution NonCommercial ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
| spellingShingle | Letter to Editor Rehman, Abdul Awais, Muhammad Baloch, Noor Ul-Ain Idarucizumab: A novel antidote for reversal of dabigatran |
| title | Idarucizumab: A novel antidote for reversal of dabigatran |
| title_full | Idarucizumab: A novel antidote for reversal of dabigatran |
| title_fullStr | Idarucizumab: A novel antidote for reversal of dabigatran |
| title_full_unstemmed | Idarucizumab: A novel antidote for reversal of dabigatran |
| title_short | Idarucizumab: A novel antidote for reversal of dabigatran |
| title_sort | idarucizumab: a novel antidote for reversal of dabigatran |
| topic | Letter to Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4732247/ https://www.ncbi.nlm.nih.gov/pubmed/26889284 http://dx.doi.org/10.4103/1793-5482.165795 |
| work_keys_str_mv | AT rehmanabdul idarucizumabanovelantidoteforreversalofdabigatran AT awaismuhammad idarucizumabanovelantidoteforreversalofdabigatran AT balochnoorulain idarucizumabanovelantidoteforreversalofdabigatran |